Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials

International Journal of Cardiology

Volumn 133, Issue 2, 2009, Pages 213-222

  De Luca, Giuseppe ^a   Stone, Gregg W ^b   Suryapranata, Harry ^c   Laarman, Gerrit Jan ^d   Menichelli, Maurizio ^e   Kaiser, Christoph ^f   Valgimigli, Marco ^g   Di Lorenzo, Emilio ^h   Dirksen, Maurits T ^d   Spaulding, Christian ⁱ   Pittl, Undine ^f   Violini, Roberto ^e   Percoco, Gianfranco ^g   Marino, Paolo ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c HOSPITAL DE WEEZENLANDEN   (Netherlands)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g UNIVERSITY OF FERRARA   (Italy)

^h Division of Cardiology   (Italy)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

DES; Meta analysis; Primary angioplast; Randomized trials; STEMI

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN; TIROFIBAN;

ACUTE HEART INFARCTION; ANGIOPLASTY; ARTICLE; BARE METAL STENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA EXTRACTION; DRUG ELUTING STENT; DRUG MEGADOSE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; META ANALYSIS; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; STENT THROMBOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 62049085079     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.040     Document Type: Article

References (50)

1. Zijlstra F., Hoorntje J.C., de Boer M.J., et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341 (1999) 1413-1419
2. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
3. Bhatt D.L., Bertrand M.E., Berger P.B., et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 39 (2002) 9-14
4. De Luca G., Suryapranata H., Stone G.W., et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293 (2005) 1759-1765
5. Zhu M.M., Feit A., Chadow H., Alam M., Kwan T., and Clark L.T. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomised clinical trials. Am J Cardiol 88 (2001) 297-301
6. De Luca G., Suryapranata H., Stone G.W., et al. Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol 126 (2008) 37-44
7. Suryapranata H., De Luca G., van 't Hof A.W., et al. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomized comparison in a large unselected cohort of patients. Heart 91 (2005) 641-645
8. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
9. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
10. Ardissino D., Cavallini C., Bramucci E., et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 292 (2004) 2727-2734
11. Colombo A., Moses J.W., Morice M.C., et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 109 (2004) 1244-1249
12. Roiron C., Sanchez P., Bouzamondo A., Lechat P., and Montalescot G. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92 (2006) 641-649
13. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
14. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
15. Spertus J.A., Kettelkamp R., Vance C., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006) 2803-2809
16. Kernis S.J., Cohen D., and Rein K. Clinical outcome associated with use of drug-eluting stents compared with bare metal stent for primary percutaneous intervention. Am J Cardiol 96 suppl 7A (2005) 47H
17. Daemen J., Tanimoto S., Garcia-Garcia H.M., et al. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 99 (2007) 1027-1032
18. Egger M., and Smith G.D. Bias in location and selection of studies. BMJ 31 (1998) 61-66
19. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 (1999) 1896-1900
20. Valgimigli M., Bolognese L., Anselmi M., et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 293 (2005) 2109-2117
21. Laarman G.J., Suttorp M.J., Dirksen M.T., et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
22. Spaulding C., Henry P., Teiger E., et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
23. Di Lorenzo E., Varricchio A., and Lanzillo T. Paclitaxel and sirolimus stent implantation in patients with acute myocardial infarction. Circulation 112 (2005) II-478 (Abstract Suppl)
24. Menichelli M., Parma A., Pucci E., et al. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 49 (2007) 1924-1930
25. Pittl U., Kaiser C., and Brunner-La Rocca H.P. Safety and efficacy of drug eluting stents versus bare metal stents in primary angioplasty of patients with acute ST-elevation myocardial infarction - a prospective randomized study. Eur Heart J 27 (2006) 650 (Abstract Suppl)
26. Sardella G., Paroli M., and Mancone M. Impact of paclitaxel-eluting stent implantation in patients with STEMI on anti-inflammatory IL-10-producing T regulatory 1 (Tr1) cells. Eur Heart J 27 (2006) 831 (Abstract Suppl)
27. Pasceri V., Granatelli A., and Pristipino C. A randomized trial of a rapamycin-eluting stent in acute myocardial infarction: preliminary results. Am J Cardiol 92 Suppl 6A (2003) 1L
28. Tierala I. The Helsinki area acute myocardial infarction treatment re-evaluation - should the patient get a drug-eluting or a normal stent (HAAMU-STENT) study, 2006. http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel=TCTMDContent&hdCon=1453095.
29. A prospective randomized controlled trial to evaluate the efficacy of drug-eluting stents versus bare-metal stents for the treatment of acute myocardial infarction (MISSION trial) (March 5 2007). http://www.cardiosource.com/clinicaltrials/browseAcronymasp?alpha=%20M www.cardiosource.com/clinicaltrials/browseAcronymasp?alpha= M
30. Chechi T., Vittori G., Biondi Zoccai G.G., et al. Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION). J Interv Cardiol 20 (2007) 282-291
31. Diaz de la Llera L., Ballesteros S., Nevado J., et al. Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty. Am Heart J 154 (2007) 164.e1-6
32. Kelbæk H, Thuesen L, Helqvist S, et al.,. Prospective, randomized comparison of drug-eluting and bare metal stents in acute myocardial infarction:8 months clinical and angiographic results. The Drug Elution and Distal Protection in ST-elevation Myocardial Infarction (DEDICATION) study, 2007. http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_pageLabel= TCTMDContent&hdCon=1518197.
33. Karjalainen. TITAX AMI Trial, 2007. http://www.tctmd.com/csportal/appmanager/tctmd/tct2007?_nfpb=true&_pageLabel=TCT2007Content&hdCon=1518259.
34. George B.S., Voorhees III W.D., Roubin G.S., et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 22 (1993) 135-143
35. Schomig A., Neumann F.J., Kastrati A., et al. A randomised comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334 (1996) 1084-1089
36. The Epistent investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 352 (1998) 87-92
37. Suryapranata H., van't Hof A.W., Hoorntje J.C., de Boer M.J., and Zijlstra F. Randomised comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 97 (1998) 2502-2505
38. Antoniucci D., Santoro G.M., Bolognese L., Valenti R., Trapani M., and Fazzini P.F. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence randomised elective stenting in acute coronary occlusion (FRESCO) trial. J Am Coll Cardiol 31 (1998) 1234-1239
39. Grines C.L., Cox D.A., Stone G.W., et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341 (1999) 1949-1956
40. Stone G.W., Grines C.L., Cox D.A., et al. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966
41. De Luca G., Ernst N., van't Hof A.W., et al. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 151 (2006) 1256-1259
42. Gibson C.M., Karha J., Murphy S.A., et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials. J Am Coll Cardiol 42 (2002) 7-16
43. Jensen L.O., Maeng M., Kaltoft A., et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 50 (2007) 463-470
44. Pasceri V., Patti G., Speciale G., Pristipino C., Richichi G., and Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 153 (2007) 749-754
45. Kastrati A., Dibra A., Spaulding C., et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28 (2007) 2706-2713
46. Pinto D.S., Stone G.W., Ellis S.G., et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol 48 (2006) 32-36
47. Valgimigli M., Bolognese L., Anselmi M., et al. Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial. Am Heart J 154 (2007) 39-45
48. Stone GW. Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction, 2007. http://clinicaltrials.gov/ct/show/NCT004%2033966?order=1.
49. Lagerqvist B., James S.K., Stenestrand U., Lindbäck J., Nilsson T., and Wallentin L. SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
50. Maisel W.H. Unanswered questions - drug-eluting stents and the risk of late thrombosis. N Engl J Med 356 (2007) 981-984